Autoimmune hepatitis is characterized by drug transporter changes resembling the panel of alterations observed in cholestatic diseases, mainly as changes in efflux transporters are present, in other words, upregulation of P-gp and MRP2 and downregulation of MRP2 [13]. The gene discussed is ABCC2; the disease is autoimmune hepatitis.